Sherry Xueying WANG

AVP-Commercialization at A*ccelerate A*STAR / Assistant Professor

Biography

Demonstrated leadership in the area of Research, Healthcare and Education industries. More than 15 years of experience in Biomedical R&D operations, intellectual property commercialization, stakeholder engagement at C-level and leading teams. Broad Therapeutic Focus Research in Oncology, Immunology, Ageing and Ageing-related human diseases. Published more than 35 international peer-reviewed journals and trained more than 50 graduate students. Prolific scientific speaker (both English and Mandarin) at reputable conferences. FMCG industry commercial lead in managing business P&L and corporate research budget.

Companies

  • AVP-Commercialization at A*ccelerate A*STAR - Agency for Science, Technology and Research (2019)
  • Associate Director, Public Policy and Regulatory Affairs for SE Asia, Global External Affairs US Pharmacopeia (2017 — 2018)
  • Head of Scientific Communications and Clinical Affairs Cerebos Pacific Limited, Brands-Suntory (2014 — 2017)
  • Principal Investigator (Head of the Laboratory) and Assistant Professor National University of Singapore (2008 — 2014)
  • Postdoctoral Scholar, Susan G. Komen Breast Cancer Foundation Fellowship University of California, San Francisco (UCSF); Genome Institute of Singapore (GIS) (2006 — 2008)

Education

  • Master of Business Administration (M.B.A.) National University of Singapore (2011 — 2014)
  • Singapore Standord Biodesign (SSB) Module National University of Singapore (2013 — 2013)
  • Doctor of Philosophy (Ph.D.) Institute of Molecular and Cell Biology (IMCB)-NUS, Singapore (2001 — 2006)
  • Graduate Diploma in International Marketing Management Development Institute of Singapore (MDIS) (2005 — 2005)
  • Bachelor of Science (B.Sc) with Honours (Hons) University of Toronto (1998 — 2001)
  • JC, Cambridge Advanced (A) Level Victorial Junior College, Singapore (1997 — 1998)

Read about executive education

Other experts

Looking for an expert?

Contact us and we'll find the best option for you.

Something went wrong. We're trying to fix this error.